Publications by authors named "Clas Sonesson"

Claim this Profile
M
Mesdopetam for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease: A Randomized Phase 2b Trial.
Angelo Antonini, Padraig O'Suilleabhain, Fabricio Stocchi, Johanna Landström, Susanna Waters, Clas Sonesson

Mov Disord Clin Pract· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-in-Human Study to Assess the Safety, Tolerability, and Pharmacokinetics of Pirepemat, a Cortical Enhancer, in Healthy Volunteers.
Erik Rein-Hedin, Folke Sjöberg, Susanna Waters, Clas Sonesson, Nicholas Waters

Clin Pharmacol Drug Dev· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A first-in-human oral dose study of mesdopetam (IRL790) to assess its safety, tolerability, and pharmacokinetics in healthy male volunteers.
Folke Sjöberg, Susanna Waters, Boel Löfberg, Clas Sonesson, Nicholas Waters

Pharmacol Res Perspect· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical Pharmacology of [2-(3-Fluoro-5-Methanesulfonyl-phenoxy)Ethyl](Propyl)amine (IRL790), a Novel Dopamine Transmission Modulator for the Treatment of Motor and Psychiatric Complications in Parkinson Disease.
Susanna Waters, Clas Sonesson, Peder Svensson, Joakim Tedroff, Manolo Carta

J Pharmacol Exp Ther· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 2a Trial Investigating the Safety and Tolerability of the Novel Cortical Enhancer IRL752 in Parkinson's Disease Dementia.
Per Svenningsson, Per Odin, Nil Dizdar, Anders Johansson, Sotirios Grigoriou, Clas Sonesson

Mov Disord· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pridopidine: Overview of Pharmacology and Rationale for its Use in Huntington's Disease.
Susanna Waters, Joakim Tedroff, Henrik Ponten, Daniel Klamer, Clas Sonesson

J Huntingtons Dis· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and tolerability of IRL790 in Parkinson's disease with levodopa-induced dyskinesia-a phase 1b trial.
Per Svenningsson, Anders Johansson, Dag Nyholm, Panagiota Tsitsi, Fredrik Hansson, Clas Sonesson

NPJ Parkinsons Dis· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Vivo Systems Response Profiling and Multivariate Classification of CNS Active Compounds: A Structured Tool for CNS Drug Discovery.
Susanna Waters, Peder Svensson, Johan Kullingsjö, Henrik Pontén, Theresa Andreasson, Clas Sonesson

ACS Chem Neurosci· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel series of 6-substituted 3-(pyrrolidin-1-ylmethyl)chromen-2-ones as selective monoamine oxidase (MAO) A inhibitors.
Cecilia Mattsson, Peder Svensson, Clas Sonesson

Eur J Med Chem· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-activity relationship of 5-chloro-2-methyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole analogues as 5-HT(6) receptor agonists.
Cecilia Mattsson, Peder Svensson, Henning Boettcher, Clas Sonesson

Eur J Med Chem· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis, pharmacological evaluation and QSAR modeling of mono-substituted 4-phenylpiperidines and 4-phenylpiperazines.
Fredrik Pettersson, Peder Svensson, Susanna Waters, Nicholas Waters, Clas Sonesson

Eur J Med Chem· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The dopaminergic stabilizer pridopidine decreases expression of L-DOPA-induced locomotor sensitisation in the rat unilateral 6-OHDA model.
Henrik Ponten, Johan Kullingsjö, Clas Sonesson, Susanna Waters, Nicholas Waters

Eur J Pharmacol· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic in vivo screening of a series of 1-propyl-4-arylpiperidines against dopaminergic and serotonergic properties in rat brain: a scaffold-jumping approach.
Cecilia Mattsson, Theresa Andreasson, Nicholas Waters, Clas Sonesson

J Med Chem· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and evaluation of a set of para-substituted 4-phenylpiperidines and 4-phenylpiperazines as monoamine oxidase (MAO) inhibitors.
Fredrik Pettersson, Peder Svensson, Susanna Waters, Nicholas Waters, Clas Sonesson

J Med Chem· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of the dopaminergic stabilizer Pridopidine (ACR16) in patients with Huntington's disease.
Anders Lundin, Espen Dietrichs, Sara Haghighi, Marie-Louise Göller, Arvid Heiberg, Clas Sonesson

Clin Neuropharmacol· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo pharmacology of the dopaminergic stabilizer pridopidine.
Henrik Ponten, Johan Kullingsjö, Sören Lagerkvist, Peter Martin, Fredrik Pettersson, Clas Sonesson

Eur J Pharmacol· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and evaluation of a set of 4-phenylpiperidines and 4-phenylpiperazines as D2 receptor ligands and the discovery of the dopaminergic stabilizer 4-[3-(methylsulfonyl)phenyl]-1-propylpiperidine (huntexil, pridopidine, ACR16).
Fredrik Pettersson, Henrik Pontén, Nicholas Waters, Susanna Waters, Clas Sonesson

J Med Chem· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The dopaminergic stabilizers pridopidine (ACR16) and (-)-OSU6162 display dopamine D(2) receptor antagonism and fast receptor dissociation properties.
Tino Dyhring, Elsebet Ø Nielsen, Clas Sonesson, Fredrik Pettersson, Jonas Karlsson

Eur J Pharmacol· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2-Alkyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indoles as novel 5-HT6 receptor agonists.
Cecilia Mattsson, Clas Sonesson, Anna Sandahl, Hartmut E Greiner, Michael Gassen

Bioorg Med Chem Lett· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The dopaminergic stabiliser ACR16 counteracts the behavioural primitivization induced by the NMDA receptor antagonist MK-801 in mice: implications for cognition.
Marie Nilsson, Arvid Carlsson, Katarina Rydén Markinhuhta, Clas Sonesson, Fredrik Pettersson

Prog Neuropsychopharmacol Biol Psychiatry· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regiochemical Control and Suppression of Double Bond Isomerization in the Heck Arylation of 1-(Methoxycarbonyl)-2,5-dihydropyrrole.
Clas Sonesson, Mats Larhed, Camilla Nyqvist, Anders Hallberg

J Org Chem· July 1996

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis